Uncategorized

Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales

Published

on

Analysts and investors alike had been eagerly awaiting sales figures for Novo Nordisk’s Wegovy pill. The answer blew past expectations by 86%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version